This is a continuation study to the Omega Tots trial (NCT01576783). The purpose of this study is to follow-up with participants of the original study to determine the long-term effect a daily fatty acid dietary supplement taken during toddlerhood might have on children born preterm now that they are 8.5-10.5 years old.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
General Cognitive Ability Score(Differential Ability Scales, Second Edition-DAS-II)
Timeframe: A single study visit when the child is between 8.5 years to 10.5 years
Core Language Score (Clinical Evaluation of Language Fundamentals, Fifth edition-CELF-5)
Timeframe: A single study visit when the child is between 8.5 years to 10.5 years
Executive Function (NIH Toolbox)
Timeframe: A single study visit when the child is between 8.5 years to 10.5 years